Chester County News and Community Website
CHESTERBROOK, PA — Persevere Therapeutics has dosed the first patient in a Phase 2a trial of misetionamide at the University of Pennsylvania’s Abramson Cancer Center, moving the experimental MYC inhibitor …
Persevere Begins Phase 2a Ovarian Cancer Trial at Penn Read More
CHESTERBROOK, PA — Persevere Therapeutics appointed oncology executive James Barlow to its board as the Chesterbrook-based biotechnology company prepares to begin a Phase 2a trial of its experimental cancer drug …
Persevere Adds Biotech CEO as Cancer Drug Enters Phase 2 Read More CHESTERBROOK, PA — Persevere Therapeutics, Inc., a clinical-stage oncology biotechnology company, announced its launch following a period of stealth operations and the initial close of a seed financing round.
Persevere Therapeutics Launches With Cancer Drug Program and Seed Funding Read More